Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

SARS-CoV-2 target regions

enabled by data from GSAID Logo

EPI_ISL ID Virus name Region Country Collection Date Navigate
EPI_ISL ID: EPI_ISL_19389709 Virus name: hCoV-19/Canada/ON-PHL-202413019/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19389708 Virus name: hCoV-19/Canada/ON-PHL-202413018/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19389707 Virus name: hCoV-19/Canada/ON-PHL-202413017/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19389706 Virus name: hCoV-19/Canada/ON-PHL-202413016/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19389700 Virus name: hCoV-19/Canada/ON-PHL-202413010/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19389690 Virus name: hCoV-19/Canada/ON-PHL-202413000/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19389689 Virus name: hCoV-19/Canada/ON-PHL-202412999/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19389688 Virus name: hCoV-19/Canada/ON-PHL-202412998/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19389687 Virus name: hCoV-19/Canada/ON-PHL-202412997/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19389685 Virus name: hCoV-19/Canada/ON-PHL-202412995/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19384361 Virus name: hCoV-19/Canada/NB-CHUDGLD-02I-MM00011U/2024 Region: North America Country: Canada Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19383565 Virus name: hCoV-19/USA/IA-SHL-2488294/2024 Region: North America Country: USA Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19383541 Virus name: hCoV-19/USA/IA-SHL-2488287/2024 Region: North America Country: USA Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19380948 Virus name: hCoV-19/Poland/Kce-429/2024 Region: Europe Country: Poland Collection Date: 2024-09-02 Go to details
EPI_ISL ID: EPI_ISL_19393123 Virus name: hCoV-19/Japan/FR012-0509/2024 Region: Asia Country: Japan Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19393563 Virus name: hCoV-19/Canada/ON-KHS-04204-v2/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19383073 Virus name: hCoV-19/Japan/FR050-0263/2024 Region: Asia Country: Japan Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19383072 Virus name: hCoV-19/Japan/FR050-0269/2024 Region: Asia Country: Japan Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19393568 Virus name: hCoV-19/Canada/ON-KHS-04209-v2/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19393567 Virus name: hCoV-19/Canada/ON-KHS-04208-v2/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19393566 Virus name: hCoV-19/Canada/ON-KHS-04207-v2/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19393565 Virus name: hCoV-19/Canada/ON-KHS-04206-v2/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19393564 Virus name: hCoV-19/Canada/ON-KHS-04205-v2/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19393545 Virus name: hCoV-19/Canada/ON-KHS-04186-v2/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19393499 Virus name: hCoV-19/Canada/ON-KHS-04132-v1/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details

Pre-calculated values are obtained by using ThermonucleotideBLAST (Gans JD, Wolinsky M. 2008), which performs in silico simulations with the NAAT methods stored in our database on the selected high-quality (<1% Ns and <0.05% unique amino acid mutations) and full length (>29,000bp) viral genomes made available by GISAID. The aims are both to detect potential target regions of the NAAT methods and to highlight possible differences with the expected reference sequence which might affect the NAAT performance.

The database contains amplicons collected by screening viral shared genomic sequences of SARSCoV- 2 by in silico determination of PCR-based molecular assays to diagnose COVID-19. The information is retrieved periodically. Acknowledgements

GISAID data provided on this website are subject to GISAID's Terms and Conditions